SEC Form 4 · accession 0000899243-16-013771
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Richman
Director
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 7:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.59 | Feb 16, 2016 | A | 20,000 | A | — | Feb 16, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2016.